Clinademi Research Pvt. Ltd., headquartered in Kolkata, is a leading Site Management Organization (SMO) dedicated to advancing high-quality clinical research across Eastern India. We are committed to raising research standards, accelerating trial outcomes, and building trusted partnerships with investigators and sponsors.

Our multidisciplinary team includes experienced clinical research professionals, esteemed Principal Investigators, skilled Clinical Research Coordinators (CRCs), and certified medical personnel. Together, we deliver comprehensive medical and operational support tailored to the unique needs of every study.

Our Expertise

• • We specialize in optimizing site operations through:

  • Expert staffing: Deployment of rigorously trained site professionals to ensure smooth day-to-day trial management.

  • Patient recruitment solutions: Strategic approaches to enhance enrollment rates and patient engagement.

  • Regulatory compliance: Strict adherence to protocols and guidelines to safeguard trial integrity.

Why Choose Clinademi Research?

• Quality-driven operations: Robust monitoring and assessment ensure seamless and compliant trial execution.

• State-of-the-art equipment: Routinely calibrated tools guarantee precision, accuracy, and reliability in all study procedures.

• Secure archival center: Dedicated facilities for compliant, secure, and systematic storage of trial documents.

• Integrated testing capabilities: Access to accredited medical laboratories for fast, accurate, and specialized diagnostics.

• At Clinademi Research, we blend scientific rigor with operational excellence, positioning ourselves as a trusted partner for clinical trials across the region.

Partner with us to experience superior site management, uncompromising data integrity, and streamlined clinical research solutions.

Our expertise in therapeutic disciplines spans a wide range of complex and specialized areas, including oncology, hematology, cardiology, respiratory care, immunology, and chronic disease management. We focus on conditions such as cancer—including breast cancer, lung cancer, lymphoma, follicular lymphoma, multiple myeloma, chronic myeloma, myelodysplastic syndromes (MDS), and chronic myelomonocytic leukemia (CMML)—as well as hematologic disorders like DLBCL, sickle cell anemia, hemophilia, myeloproliferative neoplasms, and paroxysmal nocturnal hemoglobinuria (PNH). Our expertise further extends to chronic and autoimmune conditions such as pediatric chronic kidney disease (CKD), ulcerative colitis, psoriasis, glaucoma, and diabetes. Looking ahead, we are expanding our pipeline studies into nephrology and dermatology, strengthening our commitment to advancing innovative treatments and improving patient outcomes across diverse therapeutic areas.